best stocks to purchase today


With 2016 now in the books, investors can now look ahead for 2017. Market shifts are already underway, and the year’s economic waters remain uncharted as we look to the potential effects of the new administration. Most market analysts agree that 2017 will be another positive year for growth, but, as is typically the case, new developments often create new pitfalls and potential volatility for investors. Yet, prudent, we feel that high-quality strategies are paramount when looking ahead. To that end, the following represents five of the top stocks poised for dividend growth, according our DIVCON® methodology. Using dividend growth potential as an indicator for future stock price growth, DIVCON makes an in-depth quantitative analysis to assess the likelihood that a company will grow or cut its dividend within the next twelve months, helping to uncover what we feel are quality large-cap names as a part of a dividend growth investment strategy.


 

Why Dividends are Important

best stocks to purchase today: Digital Realty Trust Inc.(DLR)

Advisors’ Opinion:

  • [By Benzinga News Desk]

    Last year was brutal for hedge fund investors — but you wouldn’t know it from the fund managers’ paychecks: Link

    ECONOMIC DATA The MBA’s index of mortgage application activity for the latest week is schedule for release at 7:00 a.m. ET. The Energy Information Administration’s weekly report on petroleum inventories in the U.S. will be released at 10:30 a.m. ET. ANALYST RATINGS Jefferies Upgraded ConocoPhillips (NYSE: COP) from Hold to Buy JPMorgan Upgraded Clovis Oncology (NASDAQ: CLVS) From Neutral to Overweight Morgan Stanley Upgrades TJX Companies (NYSE: TJX) From Equal-Weight to Overweight Macquarie Downgraded Disney (NYSE: DIS) from Outperform to Neutral Deutsche Bank Downgraded AvalonBay (NYSE: AVB) from Buy to Hold Wells Fargo Downgrades Digital Realty Trust (NYSE: DLR) From Outperform To Market Perform


    This is a tool used by the Benzinga News Desk each trading day — it's a look at everything happening in the market, in five minutes. To get the full version of this note every morning, click here or email minutes@benzinga.com.

  • [By Lisa Levin]

    DuPont Fabros Technology, Inc. (NYSE: DFT) shares shot up 10 percent to $61.07. Digital Realty Trust, Inc. (NYSE: DLR) announced plans to merge with DuPont Fabros.

best stocks to purchase today: Bacanora Minerals Ltd. (BCRMF)


Advisors’ Opinion:

  • [By SEEKINGALPHA.COM]

    The other producing lithium miners, and soon to be producers. I have discussed these previously in detail here, here and here. Needless to say, the top 3 producers are non-pure plays (SQM (NYSE:SQM), Albemarle (NYSE:ALB), and FMC Corp. (NYSE:FMC)). The top pure play currently producing miners are Orocobre (ASX:ORE) (OTCPK:OROCF), Tianqi Lithium (SHE:002466), Jiangxi Ganfeng Lithium, Galaxy Resources, Mineral Resources [ASX:MIN] (OTC:MALRF), and Neometals [ASX:NMT] (OTC:RRSSF). The near-term producers include Altura Mining [ASX:AJM] (OTCPK:ALTAF), Pilbara Minerals (ASX:PLS) (OTC:PILBF), Kidman Resources (ASX:KDR), Critical Elements, Nemaska Lithium (OTCQX:NMKEF) [TSX:NMX], Lithium Americas (OTCQX:LACDF) [TSX:LAC], Lithium X (OTCQX:LIXXF) (TSXV:LIX), Neo Lithium, and Bacanora Minerals (OTC:BCRMF) [TSXV:BCN], Advantage Lithium (OTCQB:AVLIF) [AAL], European Metals (OTCPK:MNTCF, ASX:EMH, AIM:EMH) and Pure Energy (OTCQB:PEMIF) [PE].

best stocks to purchase today: CytRx Corporation(CYTR)


Advisors’ Opinion:

  • [By Roberto Pedone]

    Another under-$10 biotechnology player that’s starting to trend within range of triggering a major breakout trade is CytRx (CYTR), which has an oncology pipeline that includes two programs in clinical development for cancer indications: aldoxorubicin and tamibarotene. This stock has been moving to the upside during the last three months, with shares up by 21%.

    If you take a look at the chart for CytRx, you’ll notice that this stock has been trending sideways inside of a consolidation chart pattern for the last two months, with shares moving between $2.27 on the downside and $2.68 on the upside. That consolidation pattern has occurred right above this stock’s 50-day and 200-day moving averages. Shares of CYTR have now started to break out above some near-term overhead resistance at $2.49 a share. That move is quickly pushing CYTR within range of triggering an even bigger breakout trade above the upper-end of its recent sideways trading chart pattern.


    Market players should now look for long-biased trades in CYTR if it manages to break out above some near-term overhead resistance levels at $2.68 to $2.80 a share with high volume. Look for a sustained move or close above those levels with volume that registers near or above its three-month average action of 154,838 shares. If that breakout triggers soon, then CYTR will set up to re-test or possibly take out its next major overhead resistance levels at $3.20 to $4 a share.

    Traders can look to buy CYTR off any weakness to anticipate that breakout and simply use a stop that sits right below its 200-day at $2.33 a share or below more support at $2.27 a share. One can also buy CYTR off strength once it clears those breakout levels with volume and then simply use a stop that sits a comfortable percentage from your entry point.

best stocks to purchase today: Gener8 Maritime, Inc.(GNRT)


Advisors’ Opinion:

  • [By Shanthi Rexaline]

    Frontline might be evaluating a new tanker company target such as Gener8 Maritime Inc (NYSE: GNRT), away from DHT Holdings Inc (NYSE: DHT), Lewis said. This was substantiated by the fact that Frontline sold 1.7 million shares of DHT in March, followed by 2.4 million shares in April and May. Though Frontline holds about 6.8 million shares of DHT, the Credit Suisse analyst said a deal is unlikely.

best stocks to purchase today: American Financial Group, Inc.(AFG)

Advisors’ Opinion:

  • [By Lee Jackson]

    Aco-chief executive officer of American Financial Group Inc. (NYSE: AFG), Carl Linder, sold a total of 200,000 shares of the property and casualty insurance products provider at prices that ranged from $90.63 to $91.62. The total for the sale was set at $18 million. The shares closed Friday at $91.55, in a52-week range of $65.38 to $92.38. The consensus price target is $95.50.

Leave a Reply

Your email address will not be published. Required fields are marked *